RBF Capital LLC Buys New Stake in TruBridge, Inc. (NASDAQ:TBRG)

RBF Capital LLC purchased a new stake in shares of TruBridge, Inc. (NASDAQ:TBRG - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 30,000 shares of the company's stock, valued at approximately $359,000. RBF Capital LLC owned about 0.20% of TruBridge at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the company. GAMMA Investing LLC purchased a new position in TruBridge in the third quarter worth approximately $26,000. Covestor Ltd purchased a new position in shares of TruBridge during the 3rd quarter worth $28,000. First Horizon Advisors Inc. purchased a new position in shares of TruBridge during the 3rd quarter worth $33,000. Point72 DIFC Ltd acquired a new stake in shares of TruBridge during the 2nd quarter worth about $56,000. Finally, FMR LLC purchased a new stake in TruBridge in the 3rd quarter valued at about $85,000. Hedge funds and other institutional investors own 88.64% of the company's stock.

TruBridge Stock Up 1.3 %

Shares of TBRG stock traded up $0.23 during trading on Friday, reaching $18.32. The company's stock had a trading volume of 82,107 shares, compared to its average volume of 142,810. TruBridge, Inc. has a 1-year low of $7.55 and a 1-year high of $18.74. The stock's 50-day moving average price is $14.38 and its 200 day moving average price is $12.25. The company has a market capitalization of $273.43 million, a price-to-earnings ratio of -4.48, a P/E/G ratio of 40.00 and a beta of 0.69. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.80 and a quick ratio of 1.78.

Analyst Ratings Changes

Several research analysts have weighed in on TBRG shares. Stephens increased their target price on shares of TruBridge from $13.00 to $17.00 and gave the stock an "equal weight" rating in a research note on Wednesday, November 20th. Royal Bank of Canada reiterated an "outperform" rating and issued a $14.00 target price on shares of TruBridge in a report on Tuesday, September 17th. Cantor Fitzgerald reissued an "overweight" rating and issued a $13.00 target price on shares of TruBridge in a research report on Friday, October 4th. Finally, Barclays raised their price target on TruBridge from $10.00 to $14.00 and gave the stock an "equal weight" rating in a research report on Monday, November 11th.

Insiders Place Their Bets

In other news, Director Mark V. Anquillare bought 2,500 shares of TruBridge stock in a transaction that occurred on Monday, November 25th. The shares were purchased at an average price of $16.81 per share, with a total value of $42,025.00. Following the completion of the acquisition, the director now directly owns 17,178 shares in the company, valued at $288,762.18. The trade was a 17.03 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Pinetree Capital Ltd. acquired 3,997 shares of the company's stock in a transaction on Wednesday, October 2nd. The stock was purchased at an average cost of $11.93 per share, for a total transaction of $47,684.21. Following the completion of the transaction, the insider now owns 603,997 shares in the company, valued at approximately $7,205,684.21. The trade was a 0.67 % increase in their position. The disclosure for this purchase can be found here. Insiders own 3.60% of the company's stock.

TruBridge Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.